TOP > 外国特許検索 > -Modified Phosphoric Acid Compound Precursor, -Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction

-Modified Phosphoric Acid Compound Precursor, -Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction

外国特許コード F210010619
整理番号 J1036-01WO
掲載日 2021年12月20日
出願国 アメリカ合衆国
出願番号 201916977525
公報番号 20210284679
出願日 平成31年3月8日(2019.3.8)
公報発行日 令和3年9月16日(2021.9.16)
国際出願番号 JP2019009213
国際出願日 平成31年3月8日(2019.3.8)
優先権データ
  • 特願2018-043329 (2018.3.9) JP
発明の名称 (英語) -Modified Phosphoric Acid Compound Precursor, -Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction
発明の概要(英語) A β-modified phosphoric acid compound precursor having a partial structure represented by ##STR00001## where A1 represents --SR1, --S--S--R1, --SeR1, or --X, where X is a halogen selected from fluorine, chlorine, bromine, and iodine; R1 represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L1 represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L2 represents an alkyl group having 1 to 20 carbon atoms, or the like; L1 and L2 may be linked to each other to form a 4 to 6-membered ring structure; L1 and L2 may each have a substituent; and the symbol * represents a bond to be bonded to a phosphate group by phosphorylation. Further, provided are a reaction inhibitor and a medicine, each of which includes the β-modified phosphoric acid compound precursor.
  • 発明者/出願人(英語)
  • Abe; Hiroshi;
  • Kimura; Yasuaki;
  • Japan Science and Technology Agency
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close